Year archive

ViroGates A/S — 2022 filings

All 46 regulatory filings released by ViroGates A/S (VIRO) in 2022, sourced directly from the official regulator.

46 Filings

2022 Period

2022 filings (46)

Filing	Released	Lang
ViroGates announces adjusted financial guidance for 2022 and 2023 Regulatory Filings	2022-12-16	English
ViroGates announces adjusted financial guidance for 2022 and 2023 Earnings Release FY 2022	2022-12-16	English
ViroGates announces CFO Mark da Silva to step down during Q1 2023 Board/Management Information	2022-12-06	English
ViroGates announces CFO Mark da Silva to step down during Q1 2023 Board/Management Information	2022-12-06	English
ViroGates notification of transactions by persons discharging managerial responsibilities according to MAR art. 19 Director's Dealing	2022-11-17	Danish
ViroGates notification of transactions by persons discharging managerial responsibilities according to MAR art. 19 Director's Dealing	2022-11-17	English
ViroGates announces the emergency use authorisation of Kineret treatment for COVID-19 related pneumonia with a post-authorisation requirement on developing suPAR tests for commercial use in the US Regulatory Filings	2022-11-10	English
ViroGates announces the emergency use authorisation of Kineret treatment for COVID-19 related pneumonia with a post-authorisation requirement on developing suPAR tests for commercial use in the US Regulatory Filings	2022-11-10	English
ViroGates announces CE-IVD approval for suPARnostic® TurbiLatex on the Beckman Coulter AU5800 platform Regulatory Filings	2022-09-23	English
ViroGates announces CE-IVD approval for suPARnostic® TurbiLatex on the Beckman Coulter AU5800 platform Regulatory Filings	2022-09-23	English
ViroGates announces its Half-Year Report for H1 2022: 62% revenue growth and new EBIT guidance Interim / Quarterly Report H1 2022	2022-08-18	English
ViroGates announces its Half-Year Report for H1 2022: 62% revenue growth and new EBIT guidance Report Publication Announcement H1 2022	2022-08-18	English
ViroGates notification of transactions by persons discharging managerial responsibilities according to MAR art. 19 Director's Dealing	2022-07-18	Danish
ViroGates notification of transactions by persons discharging managerial responsibilities according to MAR art. 19 Director's Dealing	2022-07-18	English
ViroGates notification of transactions by persons discharging managerial responsibilities according to MAR art. 19 Director's Dealing	2022-07-15	Danish
ViroGates notification of transactions by persons discharging managerial responsibilities according to MAR art. 19 Director's Dealing	2022-07-15	English
ViroGates announces the final outcome of its rights issue Share Issue/Capital Change	2022-07-08	English
ViroGates announces the final outcome of its rights issue Share Issue/Capital Change	2022-07-08	English
ViroGates announces a capital increase in connection with the exercise of warrants and grant of warrants to members of the non-executive board of directors Share Issue/Capital Change	2022-07-07	English
ViroGates announces a capital increase in connection with the exercise of warrants and grant of warrants to members of the non-executive board of directors Share Issue/Capital Change	2022-07-07	English
ViroGates announces the receipt of a debt financing proposal from Vækstfonden Capital/Financing Update	2022-06-28	English
ViroGates announces the receipt of a debt financing proposal from Vækstfonden Capital/Financing Update	2022-06-28	English
ViroGates announces financial guidance for 2022 and 2023 Earnings Release H1 2022	2022-06-22	English
ViroGates announces financial guidance for 2022 and 2023 Earnings Release FY 2022	2022-06-22	English
ViroGates announces an offering of new shares with pre-emptive rights for existing shareholders Share Issue/Capital Change	2022-06-15	English
ViroGates announces an offering of new shares with pre-emptive rights for existing shareholders Share Issue/Capital Change	2022-06-15	English
ViroGates announces the CE-IVD accreditation of its finger-prick blood-testing product, suPARnostic® POC+ Regulatory Filings	2022-05-25	English
ViroGates announces the CE-IVD accreditation of its finger-prick blood-testing product, suPARnostic® POC+ Regulatory Filings	2022-05-25	English
ViroGates announces a current total of 33 clinical routine hospital customers and adjusts its disclosure policy Regulatory Filings	2022-04-18	English
ViroGates announces a current total of 33 clinical routine hospital customers and adjusts its disclosure policy Regulatory Filings	2022-04-18	English
ViroGates announces clinical routine use in Portugal Regulatory Filings	2022-04-06	English
ViroGates announces clinical routine use in Portugal Regulatory Filings	2022-04-06	English
ViroGates issues warrants to key employees Share Issue/Capital Change	2022-03-25	English
ViroGates issues warrants to key employees Share Issue/Capital Change	2022-03-25	English
ViroGates announces its Annual Report 2021: Revenue growth of 43% and strong scientific results Report Publication Announcement	2022-03-23	English
ViroGates announces its Annual Report 2021: Revenue growth of 43% and strong scientific results Annual Report FY 2021	2022-03-23	English
ViroGates announces its Annual Report 2021: Revenue growth of 43% and strong scientific results Report Publication Announcement	2022-03-23	English
ViroGates announces its Annual Report 2021: Revenue growth of 43% and strong scientific results Report Publication Announcement FY 2021	2022-03-23	English
ViroGates announces new routine customers in Germany Regulatory Filings	2022-03-04	English
ViroGates announces new routine customers in Germany Regulatory Filings	2022-03-04	English
ViroGates announces the CE-IVD accreditation of suPARnostic® ELISA on the Chorus Trio platform marketed by Italy-based DIESSE Regulatory Filings	2022-02-17	English
ViroGates announces the CE-IVD accreditation of suPARnostic® ELISA on the Chorus Trio platform marketed by Italy-based DIESSE Regulatory Filings	2022-02-17	English
ViroGates announces a new routine customer in Finland using suPARnostic® TurbiLatex for Emergency Department triage Regulatory Filings	2022-02-10	English
ViroGates announces a new routine customer in Finland using suPARnostic® TurbiLatex for Emergency Department triage Regulatory Filings	2022-02-10	English
ViroGates announces a new routine customer in Spain using suPARnostic® TurbiLatex for suPAR guided anakinra treatment of patients with COVID-19 disease Regulatory Filings	2022-01-27	English
ViroGates announces a new routine customer in Spain using suPARnostic® TurbiLatex for suPAR guided anakinra treatment of patients with COVID-19 disease Regulatory Filings	2022-01-27	English